Metastatic Melanoma: Incorporating Lymphocyte-Activation Gene 3 Inhibitors Into the Treatment Paradigm

Are you up to date on the use of lymphocyte-activation gene 3 (LAG3) inhibitors to treat patients with metastatic melanoma?

Credit available for this activity expires: 04/21/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990930?ecd=bdc_podcast_libsyn_mscpedu